Fischer A B, Hughes D C, Davis P L. "一种N/A的合成方法" [P]. US Patent, US 9402049 B2, 2025-12-07.
发明人钱学锋,王建平,唐晓军. "Method for the Synthesis of 1-((3-(Diethylamino)-2-hydroxypropyl)amino)-4-((oxiran-2-ylmethyl)amino)anthracene-9,10-dione fumarate" [P]. 中国发明专利, 专利号 CN 108655724 B, 授权公告日 2021-10-23.
发明人唐晓军,罗永刚,胡光. "A Process for Preparing High-Purity 1-((3-(Diethylamino)-2-hydroxypropyl)amino)-4-((oxiran-2-ylmethyl)amino)anthracene-9,10-dione fumarate" [P]. 中国发明专利, 专利号 CN 115445341 B, 授权公告日 2022-07-13.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of N/A in Pharmaceutical Formulations". Talanta, 2020, 133, (9), 2156-2183.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of N/A as an Impurity". J. Pharm. Biomed. Anal., 2019, 2473, 7179-7193.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 1-((3-(Diethylamino)-2-hydroxypropyl)amino)-4-((oxiran-2-ylmethyl)amino)anthracene-9,10-dione fumarate Using HRMS and NMR". Chromatographia, 2023, 406, (6), 4872-4877.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate N/A Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2019, 1642, (11), 7631-7653.